Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-01-23
1993-08-17
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 64, A61K 31435, C07D49814
Patent
active
052369307
ABSTRACT:
The present invention provides a process for producing oxazopyrroloquinolines which comprises culturing microorganisms to produce pyrroloquinolinequinone and adding .alpha.-amino acids or monomethylamine to the resulting culture broth which contains the pyrroloquinolinequinone and from which cells of microorganisms are not separated, thereby to convert the pyrroloquinolinequinone to the corresponding oxazopyrroloquinolines.
The thus obtained oxazopyrroloquinolines include novel compounds.
The present invention further provides aldose reductase inhibitors, diabetic combined disease curing agents, immunopotentiating agents and liver disease inhibiting agents which contain as active ingredient these oxazopyrroloquinolines having excellent physiological activity.
REFERENCES:
patent: 4920117 (1990-04-01), Shutske
Hackh's Chemical Dictionary, "Amino Acids", p. 32, 1987.
The Merck Index, Tenth Edition, "DMSO", p. 475, 1983.
Forbis R. M., et al, "Nybomyain IV. Total Synthesis of Deoxynybomycin", JACS, vol. 92, No. 23 6995-6 (1970).
Europe Journal of Biochemistry, vol. 183, No. 1, 1989, pp. 41-47, Springer Berlin, DE; M. A. G. Van Kleef et al.: "Factors relevant in the reaction of pyroloquinoline quinone with amino acids. Analytical and mechanistic implications" *Abstract; p. 43, table 1, FIG. 3.
Journal of the American Chemical Society, vol. 107, No. 11, 1985, pp. 3328-3338, American Chemical Society, Washington, D.C., U.S.; P. R. Sleath et al.: "Synthesis of 7,9-didecarboxymethoxatin (4,5-dihydro-4,5-dioxo-1H-pyrrolo [2,3-f] quinoline-2-carboxylic acid) and comparison of its chemical properties with those of methoxatin and analogous o-quinones. Model studies directed toward the action of PQQ requiring bacterial oxidoreductases and mammalian plasma amine oxidase" *Structures 20a--c, 21*.
Itoh Chieko
Kobayashi Hisao
Nagai Toshio
Oda Mitsunori
Sugamura Kazuhiro
Mitbushi Gas Chemical Company, Inc.
Raymond Richard L.
LandOfFree
Oxazopyrroloquinolines and use of oxazopyrroloquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazopyrroloquinolines and use of oxazopyrroloquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazopyrroloquinolines and use of oxazopyrroloquinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2243915